2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem, designed to ...
Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare ...
ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2025 on January 30, 2025, after the stock market closes. Following the release, management ...
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Resmed ...
Good afternoon, everybody. My name is Lyanne Harrison. I am the Australian health care analyst here for Bank of America, and I cover ResMed. Today, I have the pleasure of introducing Mick Farrell, ...
NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback